| Literature DB >> 28648654 |
Jeffrey Forris Beecham Chick1, Matthew L Osher2, Kyle J Cooper2, Wael E Saad2, David M Williams2, Minhaj S Khaja2.
Abstract
Superior vena cava (SVC) syndrome, characterized by facial and arm swelling, is most frequently caused by intrathoracic malignancies. Decompression may be achieved with endovenous stent placement. Polytetrafluoroethylene-covered stents have shown to have higher long-term cumulative patency rates compared with uncovered stents for the treatment of malignant SVC syndrome. Unfortunately, polytetrafluoroethylene-covered stents are not readily available worldwide. Moreover, the existing armamentarium, including balloon-expandable iCAST stents (maximum diameter 10 mm) and heparin-coated Viabahn stent-graft endoprostheses (maximum diameter 13 mm), is too small to adequately treat malignant obstruction of the SVC. This report describes a patient with SVC syndrome and SVC tumor thrombus secondary to recurrent nonseminomatous germ cell carcinoma of the mediastinum treated with a Gianturco Z-stent-fixed modified EXCLUDER abdominal aortic aneurysm iliac limb endoprosthesis.Entities:
Mesh:
Year: 2017 PMID: 28648654 DOI: 10.1016/j.avsg.2017.06.037
Source DB: PubMed Journal: Ann Vasc Surg ISSN: 0890-5096 Impact factor: 1.466